Table 1

Patient characteristics at baseline

Patient characteristics

No CKD

(n)

No CKD

(%)

Stage 2 CKD (n)

Stage 2 CKD (%)

Stage 3 CKD

(n)

Stage 3 CKD

(%)

Stage 4 CKD

(n)

Stage 4 CKD

(%)

p-value*


All patients

2,393

-

1,032

-

357

-

147

-


Age group (years)

≤44

858

35.85

138

13.37

38

10.64

33

22.45

< .0001

45-64

1,503

62.81

812

78.68

264

73.95

104

70.75

65-74

31

1.3

79

7.66

48

13.45

9

6.12

75+

1

0.04

3

0.29

7

1.96

1

0.68


Male gender

2,121

88.63

896

86.82

300

84.03

120

81.63

0.0082


mean

SD

mean

SD

mean

SD

mean

SD


Number of comorbidities

6.85

4.81

7.51

5.33

9.68

5.83

8.19

5.53

< .0001


Charlson-Deyo Comorbidity Index score

0.44

0.87

0.55

0.94

1.25

1.43

1.33

1.66

< .0001


Age

47.83

9.02

53.71

8.5

57

8.74

51.52

9.81

< .0001


Length of follow-up (days)

912.68

449.7

927.12

455.37

896.94

428.41

936.73

467.52

0.634


eGFR (last value)

109.57

12.62

76.94

8.29

47.79

8.46

19.09

6.87

< .0001


SD = standard deviation.

Fuldeore et al. BMC Nephrology 2011 12:36   doi:10.1186/1471-2369-12-36

Open Data